Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome—A retrospective observational study

Nephrotic syndrome (NS) is associated with increased risk of venous thromboembolism (VTE). Guidelines suggest prophylactic anticoagulants to patients with high risk of thrombosis and low risk of bleeding, but the evidence behind this is poor. This study aims to investigate the effectiveness and risk...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2021-07, Vol.16 (7), p.e0255009-e0255009
Main Authors: Welander, Frida, Holmberg, Henrik, Dimény, Emöke, Jansson, Ulf, Själander, Anders
Format: Article
Language:English
Subjects:
Albumin
Albumins
Anticoagulants
Anticoagulants (Medicine)
Biology and Life Sciences
Biopsy
Bleeding
Care and treatment
Clinical medicine
Complications and side effects
Creatinine
Diabetes
Disease prevention
Drug dosages
Health risks
Kidney diseases
Kidney transplants
Laboratories
Medical records
Medicine
Medicine and Health Sciences
Nephrology
Nephrotic syndrome
Observational studies
Patient outcomes
Patients
Public health
Remission (Medicine)
Renal replacement therapy
Risk analysis
Risk factors
Statistical analysis
Thromboembolism
Thrombosis
Urine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nephrotic syndrome (NS) is associated with increased risk of venous thromboembolism (VTE). Guidelines suggest prophylactic anticoagulants to patients with high risk of thrombosis and low risk of bleeding, but the evidence behind this is poor. This study aims to investigate the effectiveness and risks of prophylactic anticoagulants (PAC) and investigate risk factors for VTE and bleeding in NS. A retrospective medical records study including adults with NS, biopsy proven glomerular disease in the county of Västernorrland, Sweden. Outcomes were VTE, bleeding and death. Patients divided into PAC- and no PAC group were compared using Fisher's exact test. Patient time was divided into serum/plasma(S/P)-albumin intervals (
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0255009